Literature DB >> 4787853

Basal prolactin blood levels in three strains of rat with differing incidence of 7,12-dimethylbenz(a)anthracene induced mammary tumours.

A R Boyns, R Buchan, E N Cole, A P Forrest, K Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4787853     DOI： 10.1016/s0014-2964(73)80015-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  9 in total

Review 1.  Hormones and neoplasia.

Authors:  A P Forrest
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

2.  Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors.

Authors:  D M Lawson; N Sensui; D H Haisenleder; P N Kaufman; R R Gala
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.

Authors:  Senthil K Muthuswamy
Journal:  Genes Dev       Date:  2012-10-15       Impact factor: 11.361

4.  Endocrinologic milieu and susceptibility of the rat mammary gland to carcinogenesis.

Authors:  D R Ciocca; A Parente; J Russo
Journal:  Am J Pathol       Date:  1982-10       Impact factor: 4.307

5.  Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo.

Authors:  D E Blask; D B Pelletier; S M Hill; A Lemus-Wilson; D S Grosso; S T Wilson; M E Wise
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  Effects of parity and serum prolactin levels on the incidence and regression of DMBA-induced tumors in OFA hr/hr rats.

Authors:  Corina V Sasso; Flavia E Santiano; Constanza M López-Fontana; Virginia Pistone-Creydt; Marcelo E Ezquer; María B Hapon; Graciela A Jahn; Rubén W Carón
Journal:  Biomed Res Int       Date:  2014-07-17       Impact factor: 3.411

7.  Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.

Authors:  Sacha J Howell; Elizabeth Anderson; Tom Hunter; Gillian Farnie; Robert B Clarke
Journal:  Breast Cancer Res       Date:  2008-08-05       Impact factor: 6.466

Review 8.  Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; D R Ciocca; I H Russo
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

9.  Plasma hormone levels and the incidence of carcinogen-induced mammary tumours in two strains of rat.

Authors:  R A Hawkins; D Drewitt; B Freedman; E Killin; D A Jenner; E H Cameron
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.